News 05 Mar 2024 Immunocore turns to Oncobit platform The British biotechnology company Immunocore will in future make use of the platform developed by Oncobit, a medtech firm and spin-off from the U...
Aktuell 05 Mar 2024 Immunocore setzt auf Plattform von Oncobit Die britische Biotech-Firma Immunocore nutzt in Zukunft die Plattform des Medtech-Unternehmens Oncobit, einer Ausgliederung der Universität Züric...
Unternehmerreisen Fact-Finding Mission to Chongqing, Dalian/Liaoyang & Beijing 24 Jun 2024–28 Jun 2024 China
News 30 Abr 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 21 Mayo 2024 InSphero partners with Genome Biologics The biotech company InSphero has signed an agreement with Genome Biologics to commercialize the 3D Cardiac Organoid Platform. The platform is at ...
News 17 Ene 2024 Spiden makes a breakthrough in non-invasive glucose measurements Spiden has made significant progress in the area of non-invasive glucose measurements. The company hopes to develop a wearable device on the basi...
Fact-Finding Mission Fact-Finding Mission to Chongqing, Dalian/Liaoyang & Beijing 24 Jun 2024–28 Jun 2024 China
News 29 Nov 2023 Meditron, EPFL’s new Large Language Model for medical knowledge EPFL researchers have unveiled Meditron, a groundbreaking open-source Large Language Model (LLM) specifically tailored for the medical field.
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Viaggi per imprenditori Fact Finding Mission: Chongqing, Dalian/Liaoyang & Pechino 24 Jun 2024–28 Jun 2024 China
News 11 Oct 2023 SFITS, the Swiss Foundation for Innovation and Training in Surgery In the intricate, ever-evolving realm of medical science, the Swiss Foundation for Innovation and Training in Surgery (SFITS) is the platform whe...
News 10 Mayo 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 26 Mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
Aktuell 22 Ene 2024 DISCO Pharmaceuticals startet mit 20 Millionen Euro Kapital DISCO Pharmaceuticals ist mit einem Startkapital von 20 Millionen Euro neu auf dem Markt. Sein Team hat als erstes eine Methode entwickelt, die e...
News 07 Mayo 2024 UZH researching innovative cancer therapy Researchers from the University of Zurich (UZH) are in the process of developing new cancer therapeutics. Known as radiotheranostics, these drugs...